Aida Perramon-Güell

Aida Perramon-Güell

Auto-generated profile, based on publicly available information

Aida Perramon-Güell

Instituto Aragonés de Ciencias de la Salud (IACS), Zaragoza, Spain

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2023 in Advanced Science
Verified
Journal Article
Open access
RNRaúl Navaridas
Raúl Navaridas
MVMaria Vidal-Sabanés
Maria Vidal-Sabanés
ARAnna Ruiz‐Mitjana
Anna Ruiz‐Mitjana
GAGisela Altés
Gisela Altés
APAida Perramon‐Güell
Aida Perramon‐Güell
XDXavier Dolcet
Xavier Dolcet
Phosphatase and TENsin homolog (Pten) and p53 are two of the most frequently mutated tumor suppressor genes in endometrial cancer. However, the functional consequences and histopathological manifestation of concomitant p53 and Pten loss of function alterations in the development of endometrial cancer is still controversial. Here, it is demonstrated that simultaneous Pten and p53 deletion is sufficient to cause epithelial to mesenchymal transition phenotype in endometrial organoids. By a novel intravaginal delivery method using HIV1 trans‐activator of transcription cell penetrating peptide fused with a Cre recombinase protein (TAT‐Cre), local ablation of both p53 and Pten is achieved specifically in the uterus. These mice developed high‐grade endometrial carcinomas and a high percentage of uterine carcinosarcomas resembling those found in humans. To further demonstrate that carcinosarcomas arise from epithelium, double Pten/p53 deficient epithelial cells are mixed with wild type stromal and myometrial cells and subcutaneously transplanted to Scid mice. All xenotransplants resulted in the development of uterine carcinosarcomas displaying high nuclear pleomorphism and metastatic potential. Accordingly, in vivo CRISPR/Cas9 disruption of Pten and p53 also triggered the development of metastatic carcinosarcomas. The results unfadingly demonstrate that simultaneous deletion of p53 and Pten in endometrial epithelial cells is enough to trigger epithelial to mesenchymal transition that is consistently translated to the formation of uterine carcinosarcomas in vivo.

4 May 2026 in Nature Aging
Verified
Journal Article
Closed access
NHNatalia Hernández-Bellido
Natalia Hernández-Bellido
APAida Perramon-Güell
Aida Perramon-Güell
CACarlos Anerillas
Carlos Anerillas

21 April 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
GAGisela Altés
Gisela Altés
AOAnna Olomí
Anna Olomí
APAida Perramon-Güell
Aida Perramon-Güell
SHSara Hernández
Sara Hernández
ACAnna Casanovas
Anna Casanovas
MEMario Encinas
Mario Encinas
Genes of the Sprouty family (Spry1-4) are feedback inhibitors of receptor tyrosine kinases, especially of Ret and the FGF receptors. As such, they play distinct and overlapping roles in embryo morphogenesis and are considered to be tumor suppressors in adult life. Genetic experiments in mice have defined in great detail the role of these genes during embryonic development, however their function in adult mice is less clearly established. Here we generate adult-onset, whole body Spry1/2/4 triple knockout mice. Tumor incidence in triple mutant mice is comparable to that of wild type littermates of up to one year of age, indicating that Sprouty loss per se is not sufficient to initiate tumorigenesis. On the other hand, triple knockout mice do not gain weight as they age, show less visceral fat, and have lower plasma glucose levels than wild type littermates, despite showing similar food intake and slightly reduced motor function. They also show alopecia, eyelid inflammation, and mild hyperthyroidism. Finally, triple knockout mice present phosphaturia and hypophosphatemia, suggesting exacerbated signaling downstream of FGF23. In conclusion, triple knockout mice develop a series of endocrine abnormalities but do not show increased tumor incidence.